Clene Inc.
CLNN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001822791
No open-market purchases or sales by Clene Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $19.6M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Clene Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- −3 vs. Q4 2022
- Shares held
- 3.03M
- +296.8K (+10.8%) vs. Q4 2022
- Total value
- $3.42M
- +$681.1K (+24.8%) vs. Q4 2022
- New holders
- 6
- 8 more added
- Sold out
- 9
- 6 more reduced
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLNN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 33 | $19.6M |
| Q1 2026 | 29 | $10.8M |
| Q4 2025 | 28 | $11.4M |
| Q3 2025 | 29 | $4.72M |
| Q2 2025 | 24 | $2.28M |
| Q1 2025 | 24 | $1.40M |
| Q4 2024 | 27 | $2.60M |
| Q3 2024 | 20 | $4.66M |
| Q2 2024 | 37 | $2.40M |
| Q1 2024 | 44 | $3.10M |
| Q4 2023 | 46 | $3.50M |
| Q3 2023 | 47 | $12.3M |
| Q2 2023 | 50 | $28.1M |
| Q1 2023 | 31 | $3.42M |
| Q4 2022 | 35 | $3.09M |
| Q3 2022 | 38 | $12.1M |
| Q2 2022 | 42 | $8.93M |
| Q1 2022 | 53 | $24.7M |
| Q4 2021 | 48 | $26.0M |
| Q3 2021 | 39 | $37.8M |
| Q2 2021 | 35 | $51.6M |
| Q1 2021 | 24 | $31.2M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Clene Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,120,776 | $1.27M | 0.00% | +188,718+20.2% | Added |
| Geode Capital Management, LLC | 314,554 | $355.4K | 0.00% | +83,749+36.3% | Added |
| Laird Norton Trust Company, LLC | 268,581 | $303.5K | 0.04% | 00.0% | Unchanged |
| Soltis Investment Advisors LLC | 218,920 | $247.4K | 0.03% | 00.0% | Unchanged |
| BlackRock Inc. | 187,111 | $211.4K | 0.00% | +1,866+1.0% | Added |
| Condor Capital Management | 165,836 | $187.4K | 0.02% | +165,836 | New |
| State Street Corp | 128,046 | $144.7K | 0.00% | +60,000+88.2% | Added |
| Bridgeway Capital Management, LLC | 100,774 | $113.9K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 89,509 | $101.1K | 0.01% | +89,509 | New |
| Two Sigma Investments, LP | 72,800 | $82.3K | 0.00% | +60,830+508.2% | Added |
| Partners Capital Investment Group, LLP | 67,855 | $76.7K | 0.00% | +67,855 | New |
| SRS Capital Advisors, Inc. | 55,250 | $62.4K | 0.01% | 00.0% | Unchanged |
| Millennium Management LLC | 51,472 | $58.0K | 0.00% | −65,665−56.1% | Reduced |
| Northern Trust Corp | 44,770 | $50.6K | 0.00% | +7,598+20.4% | Added |
| Simplex Trading, LLC | 43,973 | $49.0K | 0.00% | −48,317−52.4% | Reduced |
| Charles Schwab Investment Management Inc | 25,692 | $29.0K | 0.00% | +25,692 | New |
| Veritable, L.P. | 25,230 | $28.5K | 0.00% | 00.0% | Unchanged |
| Pallas Capital Advisors LLC | 17,341 | $17.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 10,447 | $12.0K | 0.00% | +1,111+11.9% | Added |
| Morgan Stanley | 6,289 | $7.11K | 0.00% | −10,455−62.4% | Reduced |
| Pointe Capital Management LLC | 5,200 | $5.88K | 0.00% | +5,200 | New |
| Advisor Group Holdings, Inc. | 5,000 | $5.65K | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 3,900 | $4.00K | 0.00% | −300−7.1% | Reduced |
| Washington Trust Co | 2,000 | $2.26K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,528 | $1.73K | 0.00% | −5,350−77.8% | Reduced |
| US Bancorp | 400 | $452 | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 300 | $339 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 214 | $242 | 0.00% | +3+1.4% | Added |
| Wolverine Asset Management LLC | 181 | $204 | 0.00% | +181 | New |
| UBS Group AG | 169 | $191 | 0.00% | −9,543−98.3% | Reduced |
| JPMorgan Chase & Co | 15 | $0 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −126,340−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −123,051−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −27,295−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −23,099−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −13,000−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −5,200−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −3,451−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −140−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Kepos Capital LP | – | – | – | – | Not filed |